Examining the Full Impact of CMS’ Ground-Shifting New Proposed Medicaid Drug Rebate Program Rule

March 21, 2024 8:45am

Stephanie Trunk
Partner
Arent Fox Schiff LLP

  • Reviewing how the 2023 MDRP proposed rule differs from the 2020 MDRP rule, currently in place
  • Understanding how to identify best price and calculate URAs under the proposed rule
  • Forecasting when the proposed rule will be finalized and what manufacturers will be required to follow
  • Assessing the other significant impacts the proposed rule may cause
  • Analyzing the possible legal challenges to the proposed rule
  • Exploring the large provisions on the new process for audits
  • What do manufacturers need to know